| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/20/2011 | US20110014705 Method and apparatus for separating biological materials |
| 01/20/2011 | US20110014704 Isolation of multi-lineage stem cells |
| 01/20/2011 | US20110014703 Differentiation of Human Embryonic Stem Cells |
| 01/20/2011 | US20110014702 Differentiation of Human Embryonic Stem Cells |
| 01/20/2011 | US20110014701 Protection of Progenitor Cells and Regulation of Their Differentiation |
| 01/20/2011 | US20110014700 Methods of Storing and Providing Samples of Cells and Tissue |
| 01/20/2011 | US20110014699 Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use |
| 01/20/2011 | US20110014698 Use of nanopatterned surfaces and method for enriching or isolating cellular subpopulations |
| 01/20/2011 | US20110014697 Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells |
| 01/20/2011 | US20110014696 Method for producing dendritic cells |
| 01/20/2011 | US20110014695 Methods for obtaining adult human olfactory progenitor cells |
| 01/20/2011 | US20110014694 Use of enteric glia |
| 01/20/2011 | US20110014693 Microcarriers For Stem Cell Culture |
| 01/20/2011 | US20110014692 Method of deriving progenitor cell line |
| 01/20/2011 | US20110014691 Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications |
| 01/20/2011 | US20110014673 Systems and Methods for Effecting a Physical Change in a Biological Sample |
| 01/20/2011 | US20110014667 Producing Dicarboxylic Acids Using Polyketide Synthases |
| 01/20/2011 | US20110014662 Methods for producing hyaluronan in a recombinant host cell |
| 01/20/2011 | US20110014656 Soluble il-17ra/rc fusion proteins and related methods |
| 01/20/2011 | US20110014655 Selection of host cells expressing protein at high levels |
| 01/20/2011 | US20110014654 Cell for use in prouduction of heteroproteins and production method using the same |
| 01/20/2011 | US20110014643 Neuronal Cells Cultured On Microparticles and Methods of Using Same |
| 01/20/2011 | US20110014639 Hybridoma cell line producing monoclonal antibody against foot-and-mouth disease virus, the monoclonal antibody therefrom, immunoassay reagent and kit, and immunoassay method |
| 01/20/2011 | US20110014634 Nucleic acids encoding t2r, a novel family of taste receptors |
| 01/20/2011 | US20110014624 Methods For Identifying Cells Suitable For Large-Scale Production of Recombinant Proteins |
| 01/20/2011 | US20110014622 Genetic reference materials |
| 01/20/2011 | US20110014616 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
| 01/20/2011 | US20110014612 Polymerase compositions & methods |
| 01/20/2011 | US20110014601 Targeted Chromosomal Mutagenesis Using Zinc Finger Nucleases |
| 01/20/2011 | US20110014597 Perfusable Bioreactor for the Production and/or Cultivation of a Human or Animal Blood Vessel and/or a Human or Animal Tissue |
| 01/20/2011 | US20110014307 Blood vessel maturation, normalization or stabilization agent and wrinkle preventer/improver |
| 01/20/2011 | US20110014267 Biosynthetic cartilaginous matrix and methods for their production |
| 01/20/2011 | US20110014260 System and method for liver cell culture and maturation |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014242 Promoters for expression in modified vaccinia virus ankara |
| 01/20/2011 | US20110014241 Therapeutic Cancer Antigens |
| 01/20/2011 | US20110014232 Chimeric foot and mouth disease viruses |
| 01/20/2011 | US20110014228 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 01/20/2011 | US20110014222 Stereoisomer Peptides and Their Polymer Conjugates for HIV Disease |
| 01/20/2011 | US20110014219 Norovirus and Sapovirus antigens |
| 01/20/2011 | US20110014218 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 01/20/2011 | US20110014217 Carbon nanotube compositions and methods of use thereof |
| 01/20/2011 | US20110014214 Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers |
| 01/20/2011 | US20110014213 Human anti-alpha 9 integrin antibody |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014206 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 01/20/2011 | US20110014202 Methods for Diagnosing and Treating Neuroendocrine Cancer |
| 01/20/2011 | US20110014201 Il-18 receptor antigen binding proteins |
| 01/20/2011 | US20110014200 Monoclonal antibody that suppresses thyrotropin receptor constitutive activity |
| 01/20/2011 | US20110014199 Novel anti-il 13 antibodies and uses thereof |
| 01/20/2011 | US20110014193 Humanized anti-human alpha 9-integrin antibody |
| 01/20/2011 | US20110014187 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 01/20/2011 | US20110014170 Novel alpha-galactosidases |
| 01/20/2011 | US20110014169 High affinity ny-eso t cell receptors |
| 01/20/2011 | US20110014165 Thymidylate Kinase Mutants and Uses Thereof |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014161 Cardiac Tissue-Derived Cells |
| 01/20/2011 | US20110014160 DDR1-Mediated Cell Purification of Pancreatic Endocrine Cells Through Their Progenitors |
| 01/20/2011 | US20110014159 Method for obtaining characterized muscle-derived cell populations and uses |
| 01/20/2011 | US20110014126 Use of vitamin d receptor agonists and precursors to treat fibrosis |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110014122 Novel anti-igf-ir and/or anti-insulin/igf-i hybrid receptors antibodies and uses thereof |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | US20110014119 Methods for Manipulating Phagocytosis Mediated by CD47 |
| 01/20/2011 | US20110014117 Anti-igf1r |
| 01/20/2011 | CA2768376A1 Methods and compositions for in vitro and in vivo chondrogenesis |
| 01/20/2011 | CA2768238A1 Pluripotent stem cell that can be isolated from body tissue |
| 01/20/2011 | CA2767970A1 Method for using directing cells for specific stem/progenitor cell activation and differentiation |
| 01/20/2011 | CA2767826A1 Mesenchymal stem cell differentiation using aniopoietin-like-3 |
| 01/19/2011 | EP2275818A2 Method for improved early recognition of the seroconversion of an antibody to hepatitis C |
| 01/19/2011 | EP2275575A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275574A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275566A2 Method for cellular tissue multiplication from Jatropha curcas |
| 01/19/2011 | EP2275563A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 01/19/2011 | EP2275562A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 01/19/2011 | EP2275558A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275555A2 Genetic sequence coding for creatinine deiminase, and its use |
| 01/19/2011 | EP2275550A2 Variants of ADP-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275535A1 Animal cells and processes for the replication of influenza viruses |
| 01/19/2011 | EP2275533A2 Low pressure sperm separation system using heterospermic insemination to access sperm function |
| 01/19/2011 | EP2275532A1 Myocardium-like cell sheets, three-dimensional constructes, myocardium-like tissues and processes for producing them |
| 01/19/2011 | EP2275531A1 Method for proliferation of pluripotent stem cell |
| 01/19/2011 | EP2275530A2 Method for cultivating cells for the production of compounds |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275448A2 Monovalent antibody fragments useful as therapeutics |
| 01/19/2011 | EP2275446A2 Antibodies to insulin-like growth factor I receptor |
| 01/19/2011 | EP2275445A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| 01/19/2011 | EP2275153A1 System for the manufacture of tissue engineered blood vessels |
| 01/19/2011 | EP2275152A1 Calcium-containing structures and methods of making and using the same |
| 01/19/2011 | EP2275118A2 Pancreas-specific proteins |
| 01/19/2011 | EP2274973A1 Agrobacterium-mediated method for producing transformed plant |
| 01/19/2011 | EP2274430A2 Neural regenerating cells with alterations in dna methylation |
| 01/19/2011 | EP2274424A2 Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator |
| 01/19/2011 | EP2274419A1 Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations |
| 01/19/2011 | EP2274418A2 Human host cell for producing recombinant proteins with high quality and quantity |
| 01/19/2011 | EP2274413A1 Cell container |
| 01/19/2011 | EP2273996A2 Human cardiovascular progenitor cells |
| 01/19/2011 | EP2083074B1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |